bluebird bio, Inc. (BLUE)

bluebird bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	178	574	700	2,872	4,855	5,426
Market Cap Growth	-33.40%	-18.08%	-75.61%	-40.85%	-10.51%	-33.53%
Enterprise Value	307	675	490	2,257	3,940	4,194
PE Ratio	-	-2.15	-0.85	-4.64	-6.15	-9.76
PS Ratio	8.19	159.50	191.25	-	-	99.41
PB Ratio	0.80	2.92	1.87	2.12	3.78	2.88
P/FCF Ratio	-3.80	-2.21	-1.08	-5.75	-7.64	-11.56
P/OCF Ratio	-1.17	-1.63	-1.10	-6.11	-8.60	-13.12
EV/Sales Ratio	14.15	187.60	133.93	-	-	76.84
EV/EBITDA Ratio	-4.78	-2.57	-0.61	-3.73	-4.99	-7.58
EV/EBIT Ratio	-4.57	-2.52	-0.60	-3.62	-4.88	-7.36
EV/FCF Ratio	-5.31	-2.60	-0.75	-4.52	-6.20	-8.94
Debt / Equity Ratio	1.36	1.43	0.24	0.05	0.15	0.08
Debt / EBITDA Ratio	-3.19	-1.07	-0.11	-0.11	-0.24	-0.28
Debt / FCF Ratio	-3.55	-1.09	-0.14	-0.13	-0.30	-0.33
Quick Ratio	1.24	1.41	2.03	3.36	5.01	9.56
Current Ratio	1.55	1.56	2.20	5.97	5.15	9.69
Asset Turnover	0.03	0.01	0.00	0	0	0.03
Return on Equity (ROE)	-34.30%	-133.50%	-95.60%	-43.60%	-51.20%	-32.10%
Return on Assets (ROA)	-14.40%	-49.80%	-65.20%	-33.60%	-40.60%	-27.00%
Return on Capital (ROIC)	-25.87%	-60.09%	-127.39%	-39.37%	-38.14%	-27.92%
Earnings Yield	-51.24%	-46.46%	-116.99%	-21.54%	-16.26%	-10.24%
FCF Yield	-48.13%	-45.17%	-92.83%	-17.39%	-13.09%	-8.65%
Buyback Yield / Dilution	-33.79%	-14.04%	-10.83%	-12.66%	-6.07%	-19.52%
Total Shareholder Return	-33.79%	-14.04%	-10.83%	-12.66%	-6.07%	-19.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).